Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

被引：1

作者：

Tanaka, John ^{[1
]}

Young, Rebecca ^{[2
]}

Spees, Lisa ^{[3
]}

Jenkins, Kirsten ^{[2
]}

Sung, Anthony D. ^{[4
]}

Martin, Paul L. ^{[5
]}

Heston, Sarah ^{[2
]}

Thompson, Jillian C. ^{[4
]}

Seed, Patrick ^{[6
]}

Arshad, Mehreen ^{[6
]}

Kelly, Matthew ^{[2
]}

机构：

[1] Duke Univ, Sch Med, Durham, NC USA

[2] Duke Univ, Med Ctr, Div Pediat Infect Dis, Durham, NC USA

[3] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA

[4] Duke Univ, Med Ctr, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA

[5] Duke Univ, Med Ctr, Div Pediat Blood & Marrow Transplant, Durham, NC USA

[6] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Infect Dis, Chicago, IL 60611 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-125080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1992

引用

页数：2

共 50 条

[1] Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Tanaka, John
Young, Rebecca
Heston, Sarah M.
Jenkins, Kirsten
Spees, Lisa
Sung, Anthony D.
Corbet, Kelly
Thompson, Jillian C.
Bohannon, Lauren
Martin, Paul L.
Stokhuyzen, Andre
Vinesett, Richard
Ward, Doyle, V
Bhattarai, Shakti K.
Bucci, Vanni
Arshad, Mehreen
Seed, Patrick C.
Kelly, Matthew S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2053 - 2060
[2] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Nassar, Amr
Elgohary, Ghada
Elhassan, Tusneem
Nurgat, Zubeir
Mohamed, Said Y.
Aljurf, Mahmoud
JOURNAL OF TRANSPLANTATION, 2014, 2014
[3] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Chen, Yi-Bin
Shah, Nirav N.
Renteria, Anne S.
Cutler, Corey
Jansson, Johan
Akbari, Mona
Chen, Chunlin
Quadri, Syed
Parfionovas, Andrejus
Devine, Steven M.
BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
[4] Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Omer, Aazim K.
Weisdorf, Daniel J.
Lazaryan, Aleksandr
Shanley, Ryan
Blazar, Bruce R.
MacMillan, Margaret L.
Brunstein, Claudio
Bejanyan, Nelli
Arora, Mukta
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 879 - 883
[5] Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
燕法红
ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (01) : 53 - 53
[6] Monocytes As an Early Risk Factor for Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Sun, Huimin
Hao, Sha
Dong, Fang
Wu, Linjie
Zhao, Xueying
Cheng, Tao
BLOOD, 2024, 144 : 7370 - 7371
[7] Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Sun, Huimin
Wu, Linjie
Zhao, Xueying
Huo, Yingying
Dong, Peiyuan
Pang, Aiming
Zheng, Yawei
Han, Yiwen
Ma, Shihui
Jiang, Erlie
Dong, Fang
Cheng, Tao
Hao, Sha
FRONTIERS IN IMMUNOLOGY, 2024, 15
[8] Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation
Stratton, Pamela
Turner, Maria L.
Childs, Richard
Barrett, John
Bishop, Michael
Wayne, Alan S.
Pavletic, Steven
OBSTETRICS AND GYNECOLOGY, 2007, 110 (05): : 1041 - 1049
[9] Delayed diagnosis of ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Liao, Yinglin
Zhao, Wenxin
Yang, Jing
Li, Jing
Chen, Juejing
Chen, Ziyan
Jin, Ling
Li, Longyue
Huang, Fen
Liang, Lingyi
OCULAR SURFACE, 2024, 34 : 1 - 8
[10] Diagnostic and Prognostic Biomarkers for Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Kalariya, Nilesh
Bowe, Christi
Dains, Joyce E.
ONCOLOGY NURSING FORUM, 2020, 47 (02) : E35 - E43

← 1 2 3 4 5 →